Loading...
Loading...
BioTelemetry, Inc.
BEAT, the leading wireless medical technology company focused on the
delivery of health information to improve quality of life and reduce cost of
care, announced that the Centers for Medicare and Medicaid Services ("CMS")
has published a reduction to the reimbursement for remote cardiac monitoring
services effective January 1, 2014. This reduction will impact all providers
of remote cardiac monitoring services and will result in a 13.7% decrease to
the national reimbursement rate for the MCOT^TM service. If these rates had
been in effect for 2013, we estimate that the Company's revenue would have
been negatively impacted by approximately 3.8%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in